Table 3.
Number of subjects participated in ISISEMD-controlled study.
Region | EP intervention (N = 31) | EP (intervention) dropouts since start (N = 14) | EP controls (N = 26) | Total EP subjects until end of pilot (N = 71) |
---|---|---|---|---|
FRED (Denmark) | 6 | 4 | 0 | 10 |
BLF (UK) | 7 | 5 | 10 | 22 |
TR (Greece) | 10 | 3 | 5 | 18 |
Lapp (Finland) | 8 | 2 | 11 | 21 |
| ||||
Region | ICG intervention (N = 31) | ICG (intervention) dropouts since start (N = 14) | ICG controls (N = 26) | Total ICG subjects until end of pilot (N = 71) |
| ||||
FRED (Denmark) | 6 | 4 | 0 | 10 |
BLF (UK) | 7 | 5 | 10 | 22 |
TR (Greece) | 10 | 3 | 5 | 18 |
Lapp (Finland) | 8 | 2 | 11 | 21 |